|
AU715468B2
(en)
*
|
1995-06-22 |
2000-02-03 |
Minnesota Mining And Manufacturing Company |
Stable hydroalcoholic compositions
|
|
US7566460B2
(en)
*
|
1995-06-22 |
2009-07-28 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
EP1374847A1
(en)
*
|
1995-06-22 |
2004-01-02 |
Minnesota Mining And Manufacturing Company |
Stable hydroalcoholic compositions
|
|
US6623744B2
(en)
*
|
1995-06-22 |
2003-09-23 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
US6440980B1
(en)
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
|
US6582711B1
(en)
|
1997-01-09 |
2003-06-24 |
3M Innovative Properties Company |
Hydroalcoholic compositions thickened using polymers
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU4972599A
(en)
*
|
1998-07-07 |
2000-01-24 |
Transdermal Technologies, Inc. |
Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
|
|
EP1105096B1
(en)
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
CA2360300C
(en)
*
|
1999-02-09 |
2008-08-26 |
Samyang Corporation |
A transdermal composition of an antivomiting agent and a preparation containing the same
|
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
|
US6679870B1
(en)
*
|
1999-07-23 |
2004-01-20 |
Vasca, Inc. |
Methods and kits for locking and disinfecting implanted catheters
|
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
|
US6562369B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
|
US6645520B2
(en)
*
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6558695B2
(en)
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6562368B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
|
US6562370B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20030139384A1
(en)
*
|
2000-08-30 |
2003-07-24 |
Dudley Robert E. |
Method for treating erectile dysfunction and increasing libido in men
|
|
SE0004750D0
(sv)
|
2000-12-19 |
2000-12-19 |
Astrazeneca Ab |
Novel formulation
|
|
US7247315B2
(en)
*
|
2001-08-17 |
2007-07-24 |
Lavipharm Laboratories Inc. |
Compositions and medical device for transdermal delivery of a drug and methods of making and using same
|
|
NO20014746D0
(no)
*
|
2001-09-28 |
2001-09-28 |
Clas M Kjoelberg |
Smertelindrende middel
|
|
WO2003032915A2
(en)
*
|
2001-10-16 |
2003-04-24 |
Avanir Pharmacueticals |
Viral inhibition by n-docosanol
|
|
DE10154324A1
(de)
*
|
2001-11-06 |
2003-08-07 |
Merz Pharma Gmbh & Co Kgaa |
Topisch applizierbare Zusammensetzungen mit externer Wirkstoffdepotbildung, deren Herstellung sowie deren Verwendung
|
|
OA12856A
(en)
*
|
2002-03-15 |
2006-09-15 |
Unimed Pharmaceuticals Inc |
Androgen pharmaceutical composition and method for treating depression.
|
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
US20040018163A1
(en)
*
|
2002-04-29 |
2004-01-29 |
Wei Yu |
Cosmetic compositions comprising at least one dimethicone, at least one linear hydrocarbon wax and at least one compatibilizing agent
|
|
US7192599B2
(en)
*
|
2002-06-03 |
2007-03-20 |
Mmp, Inc. |
Mattifying oil-in-water emulsion
|
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US7199090B2
(en)
*
|
2003-09-29 |
2007-04-03 |
Ethena Healthcare Inc. |
High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
DE102004062775A1
(de)
|
2004-12-21 |
2006-06-29 |
Stockhausen Gmbh |
Alkoholischer Pumpschaum
|
|
CN104739665A
(zh)
|
2005-03-07 |
2015-07-01 |
戴博全球保健有限公司 |
含有有机硅表面活性剂的高醇含量发泡组合物
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
|
US7651990B2
(en)
*
|
2005-06-13 |
2010-01-26 |
3M Innovative Properties Company |
Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
|
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
|
SI1937276T1
(sl)
|
2005-10-12 |
2013-04-30 |
Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road |
Izboljšani testosteronski gel in postopek uporabe
|
|
US20070148101A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Marcia Snyder |
Foamable alcoholic composition
|
|
US8167847B2
(en)
|
2006-06-22 |
2012-05-01 |
Excelsior Medical Corporation |
Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
|
|
EP1905302A1
(de)
*
|
2006-09-30 |
2008-04-02 |
Bayer CropScience AG |
Suspensionskonzentrate
|
|
US20080146672A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Denton Marcia Marye |
Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
|
|
US8354116B2
(en)
*
|
2007-06-18 |
2013-01-15 |
Biochemics, Inc. |
Bifunctional synthetic molecules
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
US7862877B2
(en)
*
|
2007-11-20 |
2011-01-04 |
Basic Electronics, Inc. |
Sanitary wrap
|
|
CN102414286A
(zh)
|
2009-04-28 |
2012-04-11 |
3M创新有限公司 |
水溶性压敏粘合剂
|
|
DE102010004950A1
(de)
*
|
2010-01-18 |
2011-07-21 |
Remis Gesellschaft für Entwicklung und Vertrieb von technischen Elementen mbH, 50829 |
Kühlregal mit Türvorrichtung
|
|
US8742022B2
(en)
|
2010-12-20 |
2014-06-03 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
US9296904B2
(en)
|
2010-12-20 |
2016-03-29 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
EP2729148A4
(en)
|
2011-07-06 |
2015-04-22 |
Parkinson S Inst |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
|
|
EP2861677B1
(en)
|
2012-06-19 |
2020-11-11 |
3M Innovative Properties Company |
Additive comprising low surface energy group and hydroxyl groups and coating compositions
|
|
US9701850B2
(en)
|
2012-06-19 |
2017-07-11 |
3M Innovative Properties Company |
Coating compositions comprising polymerizable non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US9638452B2
(en)
*
|
2012-09-12 |
2017-05-02 |
Celltronix |
Method and scalable devices for hyper-fast cooling and warming
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
US8785426B1
(en)
|
2013-12-13 |
2014-07-22 |
Upsher-Smith Laboratories, Inc. |
Testosterone gel compositions and related methods
|
|
WO2015139085A1
(en)
*
|
2014-03-17 |
2015-09-24 |
Gfs Corporation Aus Pty Ltd |
Antimicrobial sanitizer compositions and their use
|
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
CN109700601B
(zh)
*
|
2019-02-02 |
2022-04-22 |
天津嘉氏堂科技有限公司 |
一种水胶体硅敷料贴
|